MRVI · Maravai Lifesciences Holdings, Inc. · Executive Compensation

$7.02 -0.18 (-2.43%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.90B

259.67M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bernd Brust	Chief Executive Officer	$388,863	—	$7,660,000	$1,460,000	$425,343	$195,502	$10,129,708
William E. Martin III	Former Chief Executive Officer	$345,000	—	$2,603,552	—	—	$896,711	$3,845,263
Raj Asarpota	Chief Financial Officer	$253,366	$200,000	$2,172,500	$483,333	$195,137	$202,457	$3,506,793
Peter Leddy	Chief Administrative Officer	$372,200	—	$1,041,422	—	$115,837	$320,345	$1,849,804
Kevin Herde	Former Chief Financial Officer	$247,771	—	$1,041,422	—	—	$441,545	$1,730,738
Kurt Oreshack	Secretary and General Counsel	$455,442	—	$781,065	—	$225,320	$9,150	$1,470,977
Christine Dolan	Executive Vice President and General Manager, Cygnus	$450,966	—	$650,889	—	$343,193	$9,150	$1,454,198

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William Martin	Chief Executive Officer	$775,385	—	$4,876,608	—	$492,375	$236,031	$6,380,399
William E. Martin III	Former Chief Executive Officer	$775,385	—	$4,876,608	—	$492,375	$236,031	$6,380,399
Andrew Burch	Former President, Nucleic Acid Production	$472,583	$39,992	$1,901,878	—	$134,641	$9,150	$2,558,244
Rebecca Buzzeo	Chief Commercial Officer	$465,231	$46,800	$1,853,113	—	$94,536	—	$2,459,680
Peter Leddy	Chief Administrative Officer	$483,137	$68,139	$1,609,281	—	$137,641	$65,566	$2,363,764
Kevin Herde	Chief Financial Officer	$489,346	$69,013	$1,609,281	—	$139,406	$32,318	$2,339,364

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carl Hull	Executive Chairman and Former Interim Chief Executive Officer	$617,668	—	$2,291,342	$2,308,003	—	—	$5,217,013
Andrew Burch	Former President, Nucleic Acid Production	$371,539	$44,462	$1,993,896	$573,760	—	$9,150	$2,992,807
Peter Leddy	Chief Administrative Officer	$467,135	$75,710	$1,125,309	$1,119,073	—	$40,549	$2,827,776
Kevin Herde	Chief Financial Officer	$472,791	$66,679	$1,125,309	$1,119,073	—	$9,150	$2,793,002
William Martin	Chief Executive Officer	$750,000	—	$1,314,000	—	—	$237,864	$2,301,864
William E. Martin III	Former Chief Executive Officer	$750,000	—	$1,314,000	—	—	$237,864	$2,301,864
Christine Dolan	General Manager, Cygnus Technologies	$455,444	$70,285	$865,628	$860,825	—	$10,900	$2,263,082

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William Martin	Chief Executive Officer	$660,385	$470,000	$8,026,629	$4,427,248	$937,500	$1,731	$14,523,493
Carl Hull	Executive Chairman and Former Interim Chief Executive Officer	$721,383	—	$2,147,712	$1,879,416	$732,290	—	$5,480,801
Peter Leddy	Chief Administrative Officer	$333,654	$100,000	$1,583,640	$1,582,862	$318,150	$5,192	$3,923,498
Kevin Herde	Chief Financial Officer	$448,431	—	$513,240	$449,966	$320,695	$9,150	$1,741,482
Christine Dolan	General Manager, Cygnus Technologies	$436,557	—	$447,440	$391,545	$310,260	$9,150	$1,594,953

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carl Hull	Executive Chairman and Former Interim Chief Executive Officer	$580,769	—	—	—	$1,200,000	—	$1,780,769
Christine Dolan	General Manager, Cygnus Technologies	$411,887	—	—	—	$424,001	$8,782	$844,670
Kevin Herde	Chief Financial Officer	$412,788	—	—	—	$420,000	$8,810	$841,598

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carl Hull	Chief Executive Officer	$500,000	—	—	$874,160	$750,000	—	$2,124,160
Eric Tardif	President and Executive Vice-President,	$404,882	—	—	$874,160	$608,756	$8,550	$1,896,348
Brian Neel	Chief Operating Officer, Nucleic Acid Production	$328,609	—	—	$874,160	$649,943	$8,550	$1,861,262

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carl Hull	Chief Executive Officer	$485,417	—	—	$1,743,000	$600,000	—	$2,828,417
Brian Neel	Chief Operating Officer, Nucleic Acid Production	$314,673	—	—	$428,000	$142,436	$8,400	$893,509

Executive changes

Person	Role	Change	Effective	Filed
Murali Prahalad	Board of Directors	Resigned	2025-10-21	2025-10-27
Jessica Hopfield	Board of Directors	Resigned	2025-10-21	2025-10-27
Benjamin Daverman	Board of Directors	Resigned	2025-10-21	2025-10-27
Pete Leddy	Executive Vice President and Chief Administrative Officer	Terminated	2025-10-02	2025-08-11
Rebecca Buzzeo	Executive Vice President and Chief Commercial Officer	Terminated	2025-09-02	2025-08-11
Rajesh "Raj" Asarpota	Executive Vice President (EVP) and Chief Financial Officer (CFO)	Appointed	2025-06-30	2025-06-25
Rajesh Asarpota	Chief Financial Officer	Appointed	2025-06-30	2025-06-25
Bernd Brust	member of the Board of Directors	Appointed	2025-06-09	2025-06-09
Bernd Brust	Chief Executive Officer (CEO) and a member of the Board of Directors	Appointed	2025-06-09	2025-06-09
William E. Martin, III	member of the Board	Resigned	2025-06-08	2025-06-09
Bernd Brust	member of the Board	Appointed	2025-06-08	2025-06-09
Bernd Brust	Chief Executive Officer	Appointed	2025-06-08	2025-06-09

Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 128 filings 128 filers Visit website Investor relations